Tag Archives: downgrades

Crude prices drop on delayed Iranian crude embargo and cut to French credit rating

Posted on January 13, 2012 by Cameron White

Oil futures fell slightly on Friday after Eurozone officials said that an embargo on Iranian crude import may be delayed by up to six months. The news sent crude prices to a three-week low after the officials said that the …

Posted in Commodities, Main Post | Tagged AAA, credit rating, crude, debt crisis, downgrades, embargo, eurozone, france, futures, Greece, iranian, officials, Oil, Standard & Poor | Comments Off

Big time losers and the reasons why (PMC, WYNN, SLG)

Posted on January 12, 2012 by Cameron White

In this report: PharMerica Corp. (NYSE:PMC), Wynn Resorts (NASDAQ:WYNN) and SL Green Realty Corp. (NYSE:SLG).

PharMerica Corp. (NYSE:PMC) shares have sank by more than 7 percent today after Iit was reported that Omnicare’s proposed acquisition of PharMerica may be stopped …

Posted in Latest Headlines, Reports | Tagged cut, downgrades, Federal Trade Commission, Goldman Sachs, Kazuo Okada, keybanc markets, NASDAQ, NASDAQ:WYNN, NYSE, NYSE:PMC, NYSE:SLG, OmniCare, PharMerica Corp., PMC, rating, sell, shareholder, shares, SL Green Realty Corp., SLG, speculation, suing, The New York Post, trading, WYNN, Wynn Resorts | Comments Off

Big time losers and the reasons why (BPAX, AIS, IPSU)

Posted on December 15, 2011 by Josie Middleton

In this report: BioSante Pharmaceuticals (NASDAQ:BPAX), Antares Pharma (AMEX:AIS) and Imperial Sugar (NASDAQ:IPSU).

BioSante Pharmaceuticals (NASDAQ:BPAX) tanked by more than 77 percent today after the company’s “Female Viagra” drug failed a late stage study which then led to several downgrades …

Posted in Latest Headlines, Reports | Tagged AIS, AMEX:AIS and Imperial Sugar, analysis, Analysts, Antares Pharma, BioSante Pharmaceuticals, BPAX, company, downgrades, drug, filed, investors, IPSU, JMP Securities, late stag, Leerink, LiBiGel, MLV & Co, NASDAQ:BPAX, NASDAQ:IPSU, Oppenheimer, patents, Phase 3, report, Rodman & Renshaw, Roth Capital, S, study, tanked, testosterone, trial | Comments Off

Big time losers and the reasons why (NPSP, CYOU, FSLR)

Posted on October 31, 2011 by Martin Timble

In this report: NSP Pharmaceuticals (NASDAQ:NPSP), Changyou.com (NASDAQ:CYOU) and First Solar (NASDAQ:FSLR).

NSP Pharmaceuticals (NASDAQ:NPSP) has plummeted by more than 36 percent today after it was announce that three people who where in a clinical trial for the drug Gattex …

Posted in Latest Headlines, Reports | Tagged adjusted, Analysts, Buy, cancer, CEO, Changyou.com, clinical trial, company, CYOU, died, downgrades, earnings, estimate, expected, First Solar, FSLR, Gattex, Joe Osha, Merrill Lynch, NASDAQ:CYOU, NASDAQ:FSLR, NASDAQ:NPSP, net income, NPSP, NSP Pharmaceuticals, quarterly, rating, reported, results, revenue, Rob Gillette, share, Solar, Wall Street | Comments Off

Gold up ahead of Fed decision

Posted on September 20, 2011 by Martin Timble

Gold prices rose by 1.4 percent today on expectations that the Federal Reserve will step in to boost the economy this week. Concerns over the European debt crisis also pushed investors to put their money behind the safe haven precious …

Posted in Commodities, Main Post | Tagged bailout, concern, debt crisis, downgrades, economy, European, Fed, Federal Reserve, Gold, Greece, investors, Italy, money, ounce, payment, portfolio, precious metal, problems, safe haven, speculation, Standard & Poor, Treasuries | Comments Off

What the fuss Tesoro, Telefonica, DR Horton and Lennar?

Posted on August 31, 2011 by Martin Timble

U.S. markets are all trading slightly higher this morning as investors speculate that the Federal Reserve will again step in to boost the economy with a new stimulus package. Softer economic data was also released this morning on the private …

Posted in Main Post | Tagged analyst, Buy, company, data, DHI, Dow Jones, downgrades, DR Horton, economic, factory goods, Federal Reserve, homebuilders, investors, job growth, LEN, Lennar, Market Perform, markets, Neutral, NYSE, NYSE:DHI, NYSE:LEN, NYSE:TEF, NYSE:TSO, Oil, oil refiner, package, rating, RBC Capital, sandord berstein, sector, Spanish, speculate, stimulus, TEF, telecom, Telefnica, TES, Tesoro, trading, TSO, UBS, Underperform, upgrades | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.